Simiao pill attenuates collagen-induced arthritis and bleomycin-induced pulmonary fibrosis in mice by suppressing the JAK2/STAT3 and TGF-β/Smad2/3 signalling pathway

Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease

(2022) Mitsuhiro Akiyama et al.   AUTOIMMUNITY REVIEWS

Simiao Wan modulates the gut microbiota and bile acid metabolism during improving type 2 diabetes mellitus in mice

(2022) Yimeng Chen et al.   PHYTOMEDICINE

Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in Taiwan

(2022) Kooi-Heng Ng et al.   RMD Open

Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis associated interstitial lung disease

(2021) Scott Matson et al.   EUROPEAN RESPIRATORY JOURNAL

Rosmarinic acid protects mice from imiquimod induced psoriasis‐like skin lesions by inhibiting the IL ‐23/Th17 axis via regulating Jak2/Stat3 signaling pathway

(2021) Miaomiao Zhang et al.   PHYTOTHERAPY RESEARCH

Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis

(2021) Esteban Cano-Jiménez et al.   Scientific Reports

Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers

(2021) Antti Palomäki et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review

(2021) Esther F. Vicente-Rabaneda et al.   AUTOIMMUNITY REVIEWS

Metformin attenuates the epithelial-mesenchymal transition of lens epithelial cells through the AMPK/TGF-β/Smad2/3 signalling pathway

(2021) Ling Wang et al.   EXPERIMENTAL EYE RESEARCH

Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway

(2021) Naoki Inui et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Simiao Wan attenuates monosodium urate crystal-induced arthritis in rats through contributing to macrophage M2 polarization

(2021) Juan Yang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis

(2021) Benjamin J. Moss et al.   Annual Review of Pathology-Mechanisms of Disease

Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics

(2021) Shuchan Li et al.   CELL BIOLOGY AND TOXICOLOGY

Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/Smad2/3 pathway

(2021) Meng-yuan Qin et al.   JOURNAL OF ETHNOPHARMACOLOGY

Intravenous cyclophosphamide in acute exacerbation of rheumatoid arthritis-related interstitial lung disease: A propensity-matched analysis using a nationwide inpatient database

(2021) Kaito Nakamura et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment via the JAK2/STAT3 Signaling Pathway in Vitro

(2021) Ya Xia et al.   Frontiers in Pharmacology

Inhibition of Sirt2 Alleviates Fibroblasts Activation and Pulmonary Fibrosis via Smad2/3 Pathway

(2021) Hui Gong et al.   Frontiers in Pharmacology

WTD Attenuating Rheumatoid Arthritis via Suppressing Angiogenesis and Modulating the PI3K/AKT/mTOR/HIF-1α Pathway

(2021) Xin Ba et al.   Frontiers in Pharmacology

Management issues in rheumatoid arthritis-associated interstitial lung disease

(2020) Bryant R. England et al.   CURRENT OPINION IN RHEUMATOLOGY

Exploring and characterizing a novel combination of paeoniflorin and talatizidine for the treatment of rheumatoid arthritis

(2020) Xia Mao et al.   PHARMACOLOGICAL RESEARCH

Predictive factors of mortality in rheumatoid arthritis-associated interstitial lung disease analysed by modified HRCT classification of idiopathic pulmonary fibrosis according to the 2018 ATS/ERS/JRS/ALAT criteria

(2020) Hideaki Yamakawa et al.   Journal of Thoracic Disease

Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study

(2020) Giulia Cassone et al.   Journal of Clinical Medicine

JAK Inhibitors: Prospects in Connective Tissue Diseases

(2020) Hanxiao You et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

(2020) Fenghua Zhang et al.   EMBO Molecular Medicine

Methotrexate and rheumatoid arthritis associated interstitial lung disease

(2020) Pierre-Antoine Juge et al.   EUROPEAN RESPIRATORY JOURNAL

Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis

(2020) Hak‐Su Kim et al.   RESPIROLOGY

Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis

(2020) Thị Hằng Giang Phan et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease

(2020) Vanessa L. Kronzer et al.   JOURNAL OF RHEUMATOLOGY

Prevalence, incidence and cause-specific mortality of rheumatoid arthritis–associated interstitial lung disease among older rheumatoid arthritis patients

(2020) Jeffrey A Sparks et al.   RHEUMATOLOGY

Animal models of rheumatoid arthritis‐associated interstitial lung disease

(2020) Li Xiong et al.   Immunity Inflammation and Disease

The Jak/STAT pathway: A focus on pain in rheumatoid arthritis

(2020) Lee S. Simon et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Distinct fibroblast subsets drive inflammation and damage in arthritis

(2019) Adam P. Croft et al.   NATURE

Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis

(2019) Namrata Singh et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease

(2019) Joshua J. Solomon et al.   ADVANCES IN THERAPY

Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature

(2019) George E Fragoulis et al.   RHEUMATOLOGY

Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review

(2019) Tateiwa et al.   Cells

Guizhi-Shaoyao-Zhimu decoction possesses anti-arthritic effects on type II collagen-induced arthritis in rats via suppression of inflammatory reactions, inhibition of invasion & migration and induction of apoptosis in synovial fibroblasts

(2019) Qing Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians

(2019) Elisabeth Bendstrup et al.   Journal of Clinical Medicine

A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease

(2019) Luling Li et al.   CLINICAL RHEUMATOLOGY

Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony

(2019) Lingling Zhang et al.   PHARMACOLOGY & THERAPEUTICS

Engineered cell and tissue models of pulmonary fibrosis

(2018) Aswin Sundarakrishnan et al.   ADVANCED DRUG DELIVERY REVIEWS

Nintedanib reduces pulmonary fibrosis in a model of rheumatoid arthritis-associated interstitial lung disease

(2018) Elizabeth F. Redente et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis

(2018) Weibin Qian et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets

(2018) Justin C. Hewlett et al.   MATRIX BIOLOGY

Use of animal models in IPF research

(2018) R. Carrington et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

(2018) Ganesh Raghu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality

(2018) Karina Raimundo et al.   JOURNAL OF RHEUMATOLOGY

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

(2018) Pierre-Antoine Juge et al.   NEW ENGLAND JOURNAL OF MEDICINE

Idiopathic pulmonary fibrosis

(2017) Luca Richeldi et al.   LANCET

Pathogenetic insights from the treatment of rheumatoid arthritis

(2017) Iain B McInnes et al.   LANCET

Mesenchymal stem cells protect from hypoxia-induced alveolar epithelial-mesenchymal transition

(2016) Yurdagül Uzunhan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Management of connective tissue diseases associated interstitial lung disease

(2016) Beth Wallace et al.   CURRENT OPINION IN RHEUMATOLOGY

Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions

(2015) Veronica Della Latta et al.   PHARMACOLOGICAL RESEARCH

Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced

(2014) Robert W. Hallowell et al.   DRUGS

Lung involvement in connective tissue diseases: A comprehensive review and a focus on rheumatoid arthritis

(2013) Benedetta Marigliano et al.   AUTOIMMUNITY REVIEWS

Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review

(2013) Camille Roubille et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Animal models for arthritis: innovative tools for prevention and treatment

(2011) G. Kollias et al.   ANNALS OF THE RHEUMATIC DISEASES

Rheumatoid Arthritis–Interstitial Lung Disease–associated Mortality

(2010) Amy L. Olson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE